Shilpa Medicare gains on DRDO nod for manufacturing 2DG 0 25.06.2021 10:05 Business Standard Shilpa Medicare rose 3.85% to Rs 572 after the company announced that it had received an in-principle approval from Defence Research & Development Organisation (DRDO) to manufacture and sale of 2-Deoxy-D-Glucose (2DG). Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа Другие проекты от SMI24.net Музыкальные новости Агрегатор новостей 24СМИ
